ACLA Press Releases

  • ACLA Announces Historian and Author Doris Kearns Goodwin as Keynote Speaker for 2019 Annual Meeting

    December 17, 2018
    Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced that Doris Kearns Goodwin, world-renowned presidential historian, public speaker and Pulitzer Prize-winning author, will serve as the keynote speaker for the organization’s annual meeting on March 26, 2019. Goodwin, who published her most recent book Leadership in Turbulent Times, will offer insight and perspective on the historical political landscape and how it continuesContinue Reading »...
  • ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting

    December 04, 2018
    HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its case against the U.S. Department of Health and Human Services’ (HHS) flawed and harmful implementation of the Protecting Access to Medicare Act (PAMA). ACLA’s opening brief argues that HHS has exceeded its statutory authority, circumventing Congress’ stated directive ofContinue Reading »...
  • ACLA Statement on Final 2019 Medicare Payment Policies

    November 02, 2018
    Final rule takes preliminary steps to correct flawed data collection process; urgent Congressional action needed to protect millions of seniors from continued cuts to essential Medicare lab services   Washington, D.C. – Following the release of final Medicare payment policies, Julie Khani, President of the American Clinical Laboratory Association (ACLA) issued the following statement regarding new policy changes related to implementation of the Protecting AccessContinue Reading »...
  • ACLA Statement on Notice of Appeal in ACLA v. Azar

    October 19, 2018
    HHS’s continued reliance on faulty data collection process jeopardizes access to critical lab tests for millions of beneficiaries; ACLA files appeal following District Court decision  Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) filed its notice of appeal in its lawsuit against the U.S. Department of Health and Human Services (HHS) challenging its implementation of the Protecting Access to Medicare Act (PAMA),Continue Reading »...
  • ACLA Statement on District Court Opinion in Lawsuit Against HHS

    September 24, 2018
    Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the opinion from the U.S. District Court for the District of Columbia in ACLA v. Azar, Julie Khani, ACLA President, issued the following statement: “This is an extremely disappointing outcome for ACLA’s members and the millions of seniors they serveContinue Reading »...
  • Press Release; ACLA Submits Comments to Proposed 2019 Medicare Payment Policies

    September 11, 2018
    ...
  • ACLA Calls on CMS to Address Questionable Medicare Utilization Practices Through Stronger ‘Stark Law’ Provisions

    August 28, 2018
    Washington, D.C. – In a new comment letter to the Centers for Medicare & Medicaid Services (CMS), the American Clinical Laboratory Association called on the agency to address the long-standing abuse of the physician self-referral law (“Stark Law”) that has lead to persistent overutilization of specific services across the Medicare program. While CMS’ Request For Information on the Stark Law largely centered on howContinue Reading »...
  • AIM Coalition Urges CMS to Strengthen Medicare Self-Referral Provisions to Support Transition to Value-Based Care

    August 23, 2018
    Proposed Changes to Stark Law – Including Narrowing the In-Office Ancillary Services Exception – Would Save Medicare at Least $3.3 Billion Over Next Decade Washington, D.C. – The Medicare program could save at least $3.3 billion over the next decade by narrowing a persistent loophole in the physician self-referral law (“Stark Law”) that drives questionable utilization patterns for certain health services. The cost-savings proposalContinue Reading »...
  • ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests

    August 21, 2018
    In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) calls on Congressional leaders to enact a distinct regulatory framework for diagnostics – a key goal outlined in comments to Reps. Larry Bucshon (R-IN) and Diana DeGette (D-CO), and Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO). The commentsContinue Reading »...
  • Leading Patient, Provider, Diagnostic and Laboratory Organizations Call on Congress to Protect Seniors from Medicare Lab Cuts

    August 02, 2018
    HHS’ flawed data collection system jeopardizes beneficiary access to critical lab services Washington, D.C. – With millions of Medicare beneficiaries facing year-over-year cuts to their Medicare lab access, more than 30 leading organizations representing patients, health care professionals, laboratories and diagnostic manufacturers urged Congressional leaders to take immediate action to prevent drastic reductions to beneficiaries’ care. The letter reiterates the serious concerns regarding theContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14